Gut microbiota as potential therapeutic target for the treatment of cow's milk allergy

Nutrients

Volumn 5, Issue 3, 2013, Pages 651-662

  Berni Canani, Roberto ^a   Di Costanzo, Margherita ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Food allergy; Immune system; Intestinal microflora; Probiotics; Tolerance acquisition

Indexed keywords

FOOD ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; INTERLEUKIN 10; PROBIOTIC AGENT;

BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; CD4+ T LYMPHOCYTE; CLOSTRIDIUM; DIET SUPPLEMENTATION; FOOD ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MILK ALLERGY; NONHUMAN; PROPIONIBACTERIUM FREUDENREICHII; REVIEW;

EID: 84874927024     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5030651     Document Type: Review

References (57)

1. Skripak, J.M.; Matsui, E.C.; Mudd, K.; Wood, R.A. The natural history of IgE-mediated cow's milk allergy. J. Allergy Clin. Immun. 2007, 120, 1172-1177.
2. Berni Canani, R.; Nocerino, R.; Terrin, G.; Leone, L.; Troncone, R. Hospital admissions for food-induced anaphylaxis in Italian children. Clin. Exp. Allergy 2012, 42, 1813-1814.
3. Gourbeyre, P.; Denery, S.; Bodinier, M. Probiotics, prebiotics, and synbiotics: Impact on the gut immune system and allergic reactions. J. Leukoc. Biol. 2011, 89, 685-695.
4. Clemente, J.C.; Ursell, L.K.; Parfrey, L.W.; Knight, R. The impact of gut microbiota on human health: An integrated view. Cell 2012, 16, 1258-1270.
5. Nakayama, J.; Kobayashi, T.; Tanaka, S.; Korenori, Y.; Tateyama, A.; Sakamoto, N.; Kiyohara, C.; Shirakawa, T.; Sonomoto, K. Aberrant structures of fecal bacterial community in allergic infants profiled by 16S rRNA gene pyrosequencing. FEMS Immunol. Med. Microbiol. 2011, 63, 397-406.
6. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Available online: http://www. who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf (accessed on 13 March 2012).
7. Nutraceuticals: Global Markets and Processing Technologies. Available online: http://www. bccresearch.com/report/nutraceuticals marketsprocessing-technologies-fod013d.html (accessed on 18 June 2012).
8. Mowat, A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 2003, 3, 331-341.
9. Vighi, G.; Marcucci, F.; Sensi, L.; di Cara, G.; Frati, F. Allergy and the gastrointestinal system. Clin. Exp. Immunol. 2008, 153, 3-6.
10. Romagnani, S. Regulation of the development of type 2 T-helper cells in allergy. Curr. Opin. Immunol. 1994, 6, 838-846.
11. Bjorksten, B. Environmental influences on the development of the immune system: Consequences for disease outcome. Nestlè Nutr. Workshop Ser. Pediatr. Program. 2008, 61, 243-254.
12. Berin, M.C.; Mayer, L. Can we produce true tolerance in patients with food allergy? J. Allergy Clin. Immunol. 2013, 131, 14-22.
13. Rodriguez, B.; Prioult, G.; Hacini-Rachinel, F.; Moine, D.; Bruttin, A.; Ngom-Bru, C.; Labellie, C.; Nicolis, I.; Berger, B.; Mercenier, A.; et al. Infant gut microbiota is protective against cow's milk allergy in mice despite immature ileal T-cell response. FEMS Microbiol. Ecol. 2011, 79, 192-202.
14. Atarashi, K.; Tanoue, T.; Shima, T.; Imaoka, A.; Kuwahara, T.; Momose, Y.; Cheng, G.; Yamasaki, S.; Saito, T.; Ohba, Y.; et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331, 337-341.
15. Apostolou, E.; Pelto, L.; Kirjavainen, P.V.; Isolauri, E.; Salminen, S.J.; Gibson, G.R. Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridization. FEMS Immunol. Med. Microbiol. 2001, 30, 217-221.
16. Özdemir, Ö. Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clin. Exp. Immunol. 2010, 160, 295-304.
17. Fukushima, Y.; Kawata, Y.; Hara, H.; Terada, A.; Mitsuoka, T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol. 1998, 42, 39-44.
18. Sütas, Y.; Soppi, E.; Korhonen, H.; Syväoja, E.L.; Saxelin, M.; Rokka, T.; Isolauri, E. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J. Allergy Clin. Immunol. 1996, 98, 216-224.
19. Rosenfeldt, V.; Benfeldt, E.; Valerius, N.H.; Paerregaard, A.; Michaelsen, K.F. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr. 2004, 145, 612-616.
20. Yan, F.; Cao, H.; Cover, T.L.; Washington, M.K.; Polk, D.B. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007, 132, 562-575.
21. Rousseaux, C.; Thuru, X.; Gelot, A.; Barnich, N.; Neut, C.; Dubuquoy, L.; Dubuquoy, C.; Merour, E.; Geboes, K.; Chamaillard, M.; et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 2007, 13, 35-37.
22. Klaenhammer, T.R.; Kleerebezem, M.; Kopp, M.V.; Rescigno, M. The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 2012, 12, 729-734.
23. Van Baarlen, P.; Troost, F.J.; van Hemert, S.; van der Meer, C.; de Vos, W.M.; de Groot, P.J.; Hooiveld, G.J.; Brummer, R.J.; Kleerebezem, M. Differential NF-κ. B pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. USA 2009, 106, 2371-2376.
24. Van Baarlen, P.; Troost, F.; van der Meer, C.; Hooiveld, G.; Boekschoten, M.; Brummer, R.J.; Kleerebezem, M. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc. Natl. Acad. Sci. USA 2011, 108, 4562-4569.
25. Berni Canani, R.; di Costanzo, M.; Leone, L.; Bedogni, G.; Brambilla, P.K.; Cianfarani, S.; Nobili, V.M.; Pietrobelli, A.; Agostoni, C. Epigenetic mechanisms elicited by nutrition in early life. Nutr. Res. Rev. 2011, 24, 198-205.
26. Berni Canani, R.; di Costanzo, M.; Leone, L. The epigenetic effects of butyrate: Potential therapeutic implications for clinical practice. Clin. Epigenetics 2012, 4, 4.
27. Berni Canani, R.; di Costanzo, M.; Pezzella, V.; Cosenza, L.; Granata, V.; Terrin, G.; Nocerino, R. The potential therapeutic efficacy of Lactobacillus GG in children with food allergies. Pharmaceuticals 2012, 5, 655-664.
28. Thang, C.L.; Baurhoo, B.; Boye, J.I.; Simpson, B.K.; Zhao, X. Effects of Lactobacillus rhamnosus GG supplementation on cow's milk allergy in a mouse model. Allergy Asthma Clin. Immunol. 2011, 7, 20.
29. Berni Canani, R.; Ruotolo, S.; Discepolo, V.; Troncone, R. The diagnosis of food allergy in children. Curr. Opin. Pediatr. 2008, 20, 584-589.
30. Kalliomaki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001, 357, 1076-1079.
31. Rautava, S.; Kalliomaki, M.; Isolauri, E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol. 2002, 109, 119-121.
32. Kalliomaki, M.; Salminen, S.; Poussa, T.; Arvilommi, H.; Isolauri, E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361, 1869-1871.
33. Rautava, S.; Arvilommi, H.; Isolauri, E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr. Res. 2006, 60, 221-224.
34. Taylor, A.L.; Dunstan, J.A.; Prescott, S.L. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J. Allergy Clin. Immunol. 2007, 119, 184-191.
35. Kukkonen, K.; Savilahti, E.; Haahtela, T.; Juntunen-Backman, K.; Korpela, R.; Poussa, T.; Tuure, T.; Kuitunen, M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119, 192-198.
36. Kuitunen, M.; Kukkonen, K.; Juntunen-Backman, K.; Korpela, R.; Poussa, T.; Tuure, T.; Haahtela, T.; Savilahti, E. Probiotics prevent IgE-associated allergy until age 5 years in cesarean delivered children but not in the totalcohort. J. Allergy Clin. Immunol. 2009, 123, 335-341.
37. Abrahamsson, T.R.; Jakobsson, T.; Bottcher, M.F.; Fredrikson, M.; Jenmalm, M.C.; Björkstén, B.; Oldaeus, G. Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119, 1174-1180.
38. Kopp, M.V.; Hennemuth, I.; Heinzmann, A.; Urbanek, R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics 2008, 121, e850-e856.
39. Wickens, K.; Black, P.N.; Stanley, T.V.; Mitchell, E.; Fitzharris, P.; Tannock, G.W.; Purdie, G.; Crane, J.; Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: A doubleblind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2008, 122, 788-794.
40. Huurre, A.; Laitinen, K.; Rautava, S.; Korkeamaki, M.; Isolauri, E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: A double-blind placebo-controlled study. Clin. Exp. Allergy 2008, 38, 1342-1348.
41. Soh, S.E.; Aw, M.; Gerez, I.; Rauff, M.; Ng, Y.P.; Wong, H.B.; Pai, N.; Lee, B.W.; Shek, L.P. Probiotic supplementation in the first 6 months of life in at risk Asian infants-Effects on eczema and atopic sensitization at the age of 1 year. Clin. Exp. Allergy 2009, 39, 571-578.
42. Niers, L.; Martín, R.; Rijkers, G.; Sengers, F.; Timmerman, H.; van Uden, N.; Smidt, H.; Kimpen, J.; Hoekstra, M. The effects of selected probiotic strains on 1 the development of eczema (The PandA study). Allergy 2009, 64, 1349-1358.
43. West, C.E.; Hammarstrom, M.L.; Hernell, O. Probiotics during weaning reduce the incidence of eczema. Pediatr. Allergy Immunol. 2009, 20, 430-437.
44. Dotterud, C.; Oien, T.; Storro, O.; Johnsen, R. Probiotic supplementation given to mothers in primary prevention of allergic diseases in early childhood-A randomised controlled trial in an unselected population. Allergy 2009, 64, 64.
45. Kim, J.Y.; Kwon, J.H.; Ahn, S.H.; Lee, S.I.; Han, Y.S.; Choi, Y.O.; Lee, S.Y.; Ahn, K.M.; Ji, G.E. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. 2010, 21, e386-e393.
46. Boyle, R.J.; Ismail, I.H.; Kivivuori, S.; Licciardi, P.V.; Robins-Browne, R.M.; Mah, L.J.; Axelrad, C.; Moore, S.; Donath, S.; Carlin, J.B.; et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: A randomized controlled trial. Allergy 2011, 66, 509-516.
47. Rautava, S.; Kainonen, E.; Salminen, S.; Isolauri, E. Maternal probiotic supplementation during pregnacy and breast feeding reduces the risk of eczema in infant. J. Allergy Clin. Immunol. 2012, 130, 1355-1360.
48. Majamaa, H.; Isolauri, E. Probiotics: A novel approach in the management of food allergy. J. Allergy Clin. Immun. 1997, 99, 179-185.
49. Isolauri, E.; Arvola, T.; Sutas, Y.; Moilanen, E.; Salminen, S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 2000, 30, 1604-1610.
50. Isolauri, E. Studies on Lactobacillus GG in food hypersensitivity disorders. Nutr. Today Suppl. 1996, 31, 285-315.
51. Nermes, M.; Kantele, J.M.; Atosuo, T.J.; Salminen, S.; Isolauri, E. Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin. Exp. Allergy 2010, 41, 370-377.
52. Pohjavuori, E.; Viljanen, M.; Korpela, R.; Kuitunen, M.; Tiittanen, M.; Vaarala, O.; Savilahti, E. Lactobacillus GG effect in increasing IFN-γ. production in infants with cow's milk allergy. J. Allergy Clin. Immun. 2004, 114, 131-136.
53. Baldassarre, M.E.; Laforgia, N.; Fanelli, M.; Laneve, A.; Grosso, R.; Lifschitz, C. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. J. Pediatr. 2010, 156, 397-401.
54. Hol, J.; van Leer, E.H.; Elink Schuurman, B.E.; de Ruiter, L.F.; Samsom, J.N.; Hop, W.; Neijens, H.J.; de Jongste, J.C.; Nieuwenhuis, E.E.; Cow's Milk Allergy Modified by Elimination and Lactobacilli study group. The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial. J. Allergy Clin. Immunol. 2008, 121, 1448-1454.
55. Berni Canani, R.; Nocerino, R.; Terrin, G.; Coruzzo, A.; Cosenza, L.; Leone, L.; Troncone, R. Effect of extensively hydrolyzed casein formula supplemented with Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: A randomized trial. J. Allergy Clin. Immun. 2012, 129, 580-582.
56. Muraro, A.; Hoekstra, M.O.; Meijer, Y.; Lifschitz, C.; Wampler, J.L.; Harris, C.; Scalabrin, D.M. Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: Randomized double-blind, placebo-controlled crossover trial. BMJ Open 2012, 5, 2.
57. Martín-Muñoz, M.F.; Fortuni, M.; Caminoa, M.; Belver, T.; Quirce, S.; Caballero, T. Anaphylactic reaction to probiotics. Cow's milk and hen's egg allergens in probiotic compounds. Pediatr. Allergy Immunol. 2012, 23, 778-784.